Core Viewpoint - The stock price of Haishike has experienced a decline, with a current trading price of 50.70 yuan per share, reflecting a year-to-date drop of 1.21% and a 5-day drop of 5.62% [1] Financial Performance - For the period from January to September 2025, Haishike achieved an operating revenue of 3.3 billion yuan, representing a year-on-year growth of 19.95%. However, the net profit attributable to shareholders decreased by 22.66% to 295 million yuan [2] - Cumulatively, Haishike has distributed a total of 3.673 billion yuan in dividends since its A-share listing, with 687 million yuan distributed over the past three years [3] Shareholder Structure - As of September 30, 2025, the number of shareholders of Haishike increased by 12.87% to 12,900, with an average of 37,342 circulating shares per person, down by 11.40% [2] - The top ten circulating shareholders include notable funds such as China Europe Medical Health Mixed A and Hong Kong Central Clearing Limited, with varying changes in their holdings [3] Market Activity - As of January 22, Haishike's stock saw a trading volume of 51.53 million yuan, with a turnover rate of 0.21% and a total market capitalization of 56.78 billion yuan [1] - The main capital flow indicated a net outflow of 6.3653 million yuan, with significant selling activity observed [1]
海思科跌2.01%,成交额5153.05万元,主力资金净流出636.53万元